Latest Regulatory Progress News

Neuren Pharmaceuticals’ partner Acadia projects DAYBUE sales to reach around US$700 million by 2028, driven by US market expansion and international approvals. The launch of a new formulation and ongoing clinical trials in Japan underpin this optimistic outlook.

Proteomics International Laboratories has appointed David Morris as CEO and Managing Director, marking a strategic shift towards commercialising its Promarker® diagnostic technology. Morris brings extensive global healthcare leadership experience to lead the company’s next growth phase.

Brightstar Resources has secured key regulatory approvals for the Lady Shenton open pit mine in Menzies, positioning the company to accelerate production within its Goldfields Hub. The deposit is now 'mine ready' and will feed into Brightstar’s planned Laverton processing plant.

Rox Resources has ramped up underground mining and advanced processing plant development at its Youanmi Gold Project, signalling a strong push towards production in 2026. Key infrastructure expansions and strategic hires underpin the company’s growth ambitions.

Ore Resources Ltd has identified nine promising gold targets at its Randalls North tenements through detailed geophysical and geochemical analysis, setting the stage for an active 2026 exploration campaign.

St George Mining has announced a significant high-grade niobium discovery 400 metres outside its existing Araxá Mineral Resource Estimate, potentially expanding one of the world’s premier niobium projects.

Island Pharmaceuticals has been granted a key US patent for Galidesivir, extending intellectual property protection through 2031 for treating filoviridae viruses including Marburg and Ebola. This milestone aligns with the company’s clinical development strategy and recent FDA regulatory progress.

Titanium Sands Limited has lodged an Industrial Mining License application for its Mannar Heavy Minerals Project in Sri Lanka, marking a pivotal step towards production. The project boasts a substantial mineral resource and is progressing through environmental and feasibility milestones despite recent cyclone delays.

Global Laser Enrichment, licensee of Silex’s laser uranium enrichment technology, has won a $28 million U.S. Department of Energy award to push next-gen nuclear fuel innovation, despite missing out on a larger $900 million contract.

Nexsen Limited has initiated FDA engagement for its rapid Group B Streptococcus diagnostic sensor, aiming for expedited US market entry, while bolstering its leadership team and scientific credentials.

New Frontier Minerals has moved its Mining Lease Application for the Big One Copper Deposit into the technical assessment phase, marking a key step toward near-term development amid a strong copper market.

Kingsland Minerals has initiated a Pre-feasibility Study for its Leliyn Graphite Project and commenced key metallurgical testing with offtake partner Quinbrook, aiming to produce battery-grade spherical graphite.